Revolutionizing the Gray Market: Peptide Guru Dra Hazel Kulvar Launches Public ICO for "Peptide Swap" Marketplace

The booming global peptide market-which has quietly soared to nearly $4 billion in revenue despite sitting primarily in phase 3 trials and relying heavily on traditional gray-market channels-is about to experience a seismic shift. Renowned peptide expert and industry leader Dra Hazel Kulvar has officially announced the launch of the public initial coin offering (ICO) round for the highly anticipated 'Peptide Swap' ecosystem, hosted at www.PeptideSwap.com.

Designed to bridge the gap between decentralized finance and specialized chemical research materials, the platform aims to capture explosive market demand while bringing unprecedented transparency and security to enthusiasts, everyday users, and crypto investors alike.

Powering the Ecosystem: The $PEPS Token

At the heart of this financial and commercial evolution is the official native currency of the marketplace: the "$PEPS" ERC-20 token, operating securely on the Ethereum blockchain. As the marketplace opens and transactional activity scales, buying pressure driven by ecosystem products-starting with the flagship Peptide Swap platform-will directly influence the asset's trajectory. Early token holders stand to see their investments grow and compound organically alongside the platform's overall usage and commercial milestones.

Project founders are bullish on adoption, projecting that Peptide Swap could easily clear over $20 million in transaction volume within its very first year if current gray-market momentum persists. To ensure long-term value, every transaction executed on the marketplace will carry a small fee. A portion of these fees will automatically trigger a buy-back mechanism for $PEPS tokens, sending them directly to a permanently locked wallet to burn supply, drive up scarcity, and bolster token value over time.

Solving the Gray Market Trust Deficit

For years, acquiring research-grade compounds has been plagued by operational risks, opaque sourcing, and fraudulent operators. Dra Hazel Kulvar, who has been active in the space, emphasizes that the platform is engineered as a definitive countermeasure.

"The Peptide Swap Marketplace is a solution for the growing issue of crypto rip-offs," says Dra Hazel Kulvar. "We want to use the new platform to help ensure users of research-grade materials have a safe place to purchase peptides using cryptos and know they cannot be swindled."

Beyond secure crypto-commerce escrow features, the ecosystem introduces accountability through community-driven infrastructure. Users will be empowered to leave public, transparent reviews of verified vendors' products, with a specialized focus on compound purity and lab-verified quality standards.

Comprehensive Selection of Popular Research Compounds

To cater to the diverse demands of the global community, the marketplace will host a comprehensive catalog spanning all major compound categories. The initial rollout will support transactions for the 25 most popular peptides currently driving research interest:

1. BPC-157
2. TB-500
3. CJC-1295
4. Ipamorelin
5. Sermorelin
6. AOD-9604
7. Tesamorelin
8. Selank
9. Semax
10. GHK-Cu
11. MOTS-c
12. KPV
13. Thymosin Alpha-1
14. Epitalon
15. SS-31
16. Melanotan II
17. IGF-1 LR3
18. PT-141 (Bremelanotide)
19. FoxO4-DRI
20. Pinealon
21. Cortagen
22. DSIP (Delta Sleep-Inducing Peptide)
23. ARA-290
24. LL-37
25. VIP (Vasoactive Intestinal Peptide)

Looking Ahead: Beta Launch and Beyond

Peptide Swap is structured to be only the first foundational milestone for the $PEPS token ecosystem, with subsequent utility projects slated for formal announcement as the presale advances through upcoming investment rounds.

Crypto investors and research participants looking to secure allocations can access the public ICO round directly at www.PeptideSwap.com. Meanwhile, developers have confirmed that a beta version of the Peptide Swap marketplace is on track to debut before January 2027. This initial rollout will serve as the platform's first live stress test, allowing developers to study user habits, optimize transaction flow, and deliver a frictionless commercial experience by launch day.

BioHack Pub LLC
P.O. Box 802
George Town, Grand Cayman
KY1-1100 CAYMAN ISLANDS

Official Peptide Swap
peptideswap.com
contact PR@PeptideSwap.com

BioHack Pub LLC stands at the forefront of scientific communication as a premier research material news and press relations agency. Dedicated to amplifying breakthroughs in biotechnology, life sciences, and advanced research, BioHack Pub empowers the industry's most innovative solutions to break through the noise and establish dominant brand authority.

By bridging the gap between complex scientific discovery and public engagement, BioHack Pub delivers strategic media campaigns, targeted press distributions, and high-impact storytelling. The agency specializes in translating intricate data and laboratory milestones into compelling narratives that captivate investors, industry leaders, and academic communities alike.

Through its rigorous commitment to accuracy, transparency, and cutting-edge PR strategies, BioHack Pub ensures that pioneering biotech firms and research material providers do more than just share findings-they build lasting, trusted global brands. Whether launching a novel compound, announcing a major patent, or scaling market presence, BioHack Pub provides the essential megaphone for science that changes the world.

Would you like to tailor this bio for a specific platform, such as LinkedIn, a press kit, or an official website "About Us" page?

This release was published on openPR.